XERS logo

Xeris Biopharma Holdings, Inc. (XERS) Operating Profit

Annual Operating Profit:

-$33.65M+$10.36M(+23.55%)
December 31, 2024

Summary

  • As of today, XERS annual operating income is -$33.65 million, with the most recent change of +$10.36 million (+23.55%) on December 31, 2024.
  • During the last 3 years, XERS annual operating profit has risen by +$81.51 million (+70.78%).
  • XERS annual operating profit is now -154.30% below its all-time high of -$13.23 million, reached on December 31, 2016.

Performance

XERS Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

Quarterly Operating Profit:

$6.73M+$2.25M(+50.18%)
September 30, 2025

Summary

  • As of today, XERS quarterly operating income is $6.73 million, with the most recent change of +$2.25 million (+50.18%) on September 30, 2025.
  • Over the past year, XERS quarterly operating profit has increased by +$19.62 million (+152.21%).
  • XERS quarterly operating profit is now at all-time high.

Performance

XERS Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

TTM Operating Profit:

$9.80M+$19.62M(+199.80%)
September 30, 2025

Summary

  • As of today, XERS TTM operating income is $9.80 million, with the most recent change of +$19.62 million (+199.80%) on September 30, 2025.
  • Over the past year, XERS TTM operating profit has increased by +$54.97 million (+121.70%).
  • XERS TTM operating profit is now at all-time high.

Performance

XERS TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

XERS Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+23.6%+152.2%+121.7%
3Y3 Years+70.8%+136.0%+109.4%
5Y5 Years+72.5%+152.0%+110.2%

XERS Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+70.8%at high+136.0%at high+109.4%
5Y5-Yearat high+72.5%at high+117.3%at high+108.4%
All-TimeAll-Time-154.3%+72.5%at high+117.3%at high+107.8%

XERS Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
$6.73M(+50.2%)
$9.80M(+199.8%)
Jun 2025
-
$4.48M(+245.0%)
-$9.82M(+56.3%)
Mar 2025
-
-$3.09M(-284.0%)
-$22.49M(+33.2%)
Dec 2024
-$33.65M(+23.5%)
$1.68M(+113.0%)
-$33.65M(+25.5%)
Sep 2024
-
-$12.89M(-57.5%)
-$45.17M(-21.5%)
Jun 2024
-
-$8.19M(+42.5%)
-$37.19M(+17.3%)
Mar 2024
-
-$14.24M(-44.8%)
-$44.98M(-2.2%)
Dec 2023
-$44.01M(+46.3%)
-$9.84M(-100.3%)
-$44.01M(+10.8%)
Sep 2023
-
-$4.91M(+69.3%)
-$49.34M(+21.8%)
Jun 2023
-
-$15.98M(-20.4%)
-$63.13M(+4.4%)
Mar 2023
-
-$13.28M(+12.5%)
-$66.07M(+17.9%)
Dec 2022
-$81.94M(+28.8%)
-$15.17M(+18.9%)
-$80.45M(+22.8%)
Sep 2022
-
-$18.70M(+1.1%)
-$104.15M(+5.1%)
Jun 2022
-
-$18.92M(+31.6%)
-$109.81M(+5.7%)
Mar 2022
-
-$27.66M(+28.8%)
-$116.48M(-10.7%)
Dec 2021
-$115.16M
-$38.87M(-59.6%)
-$105.26M(-24.1%)
Sep 2021
-
-$24.36M(+4.8%)
-$84.83M(-15.5%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$25.59M(-55.6%)
-$73.41M(-4.8%)
Mar 2021
-
-$16.44M(+10.9%)
-$70.03M(+14.4%)
Dec 2020
-$83.55M(+31.7%)
-$18.44M(-42.5%)
-$81.85M(+14.9%)
Sep 2020
-
-$12.94M(+41.7%)
-$96.20M(+15.1%)
Jun 2020
-
-$22.20M(+21.4%)
-$113.34M(+9.5%)
Mar 2020
-
-$28.25M(+13.9%)
-$125.20M(-2.3%)
Dec 2019
-$122.38M(-106.2%)
-$32.80M(-9.0%)
-$122.38M(-11.4%)
Sep 2019
-
-$30.08M(+11.7%)
-$109.89M(-16.0%)
Jun 2019
-
-$34.06M(-33.9%)
-$94.75M(-29.7%)
Mar 2019
-
-$25.44M(-25.2%)
-$73.05M(-23.1%)
Dec 2018
-$59.34M(-122.9%)
-$20.31M(-35.9%)
-$59.34M(-52.0%)
Sep 2018
-
-$14.94M(-20.9%)
-$39.03M(-23.3%)
Jun 2018
-
-$12.36M(-5.3%)
-$31.66M(-64.0%)
Mar 2018
-
-$11.73M(-54.9%)
-$19.30M(-57.9%)
Dec 2017
-$26.63M(-101.3%)
-
-
Sep 2017
-
-$7.57M(-62.9%)
-$12.22M(-162.9%)
Mar 2017
-
-$4.65M
-$4.65M
Dec 2016
-$13.23M
-
-

FAQ

  • What is Xeris Biopharma Holdings, Inc. annual operating income?
  • What is the all-time high annual operating profit for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. annual operating profit year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. quarterly operating profit year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. TTM operating profit year-on-year change?

What is Xeris Biopharma Holdings, Inc. annual operating income?

The current annual operating profit of XERS is -$33.65M

What is the all-time high annual operating profit for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high annual operating income is -$13.23M

What is Xeris Biopharma Holdings, Inc. annual operating profit year-on-year change?

Over the past year, XERS annual operating income has changed by +$10.36M (+23.55%)

What is Xeris Biopharma Holdings, Inc. quarterly operating income?

The current quarterly operating profit of XERS is $6.73M

What is the all-time high quarterly operating profit for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high quarterly operating income is $6.73M

What is Xeris Biopharma Holdings, Inc. quarterly operating profit year-on-year change?

Over the past year, XERS quarterly operating income has changed by +$19.62M (+152.21%)

What is Xeris Biopharma Holdings, Inc. TTM operating income?

The current TTM operating profit of XERS is $9.80M

What is the all-time high TTM operating profit for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high TTM operating income is $9.80M

What is Xeris Biopharma Holdings, Inc. TTM operating profit year-on-year change?

Over the past year, XERS TTM operating income has changed by +$54.97M (+121.70%)
On this page